Calcium Signaling and Cardiac Arrhythmias

2017/06/08 by Andrew P. Landstrom, Dobromir Dobrev, Xander H.T. Wehrens · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cardiac electrophysiology and arrhythmias #Ion channel regulation and function #Cardiomyopathy and Myosin Studies

paper · pdf · doi:10.1161/circresaha.117.310083

Abstract

There has been a significant progress in our understanding of the molecular mechanisms by which calcium (Ca 2+ ) ions mediate various types of cardiac arrhythmias. A growing list of inherited gene defects can cause potentially lethal cardiac arrhythmia syndromes, including catecholaminergic polymorphic ventricular tachycardia, congenital long QT syndrome, and hypertrophic cardiomyopathy. In addition, acquired deficits of multiple Ca 2+ -handling proteins can contribute to the pathogenesis of arrhythmias in patients with various types of heart disease. In this review article, we will first review the key role of Ca 2+ in normal cardiac function—in particular, excitation–contraction coupling and normal electric rhythms. The functional involvement of Ca 2+ in distinct arrhythmia mechanisms will be discussed, followed by various inherited arrhythmia syndromes caused by mutations in Ca 2+ -handling proteins. Finally, we will discuss how changes in the expression of regulation of Ca 2+ channels and transporters can cause acquired arrhythmias, and how these mechanisms might be targeted for therapeutic purposes.

Citations

• A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Cited by

• Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies
• CRISPR Modeling and Correction of Cardiovascular Disease
• Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists. [europepmc]
• Role of inflammatory signaling in atrial fibrillation. [europepmc]
• Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure. [europepmc]
• In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia. [europepmc]
• Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. [europepmc]
• Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic β cell. [europepmc]
• Human Calmodulin Mutations. [europepmc]
• Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies. [europepmc]
• Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation. [europepmc]
• Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes. [europepmc]
• Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. [europepmc]
• Cardiac TRPV1 afferent signaling promotes arrhythmogenic ventricular remodeling after myocardial infarction. [europepmc]
• Calcium Handling Defects and Cardiac Arrhythmia Syndromes. [europepmc]
• Increased RyR2 activity is exacerbated by calcium leak-induced mitochondrial ROS. [europepmc]
• Targeting Calcium Homeostasis in Myocardial Ischemia/Reperfusion Injury: An Overview of Regulatory Mechanisms and Therapeutic Reagents. [europepmc]
• Clinical manifestations and management of fatty acid oxidation disorders. [europepmc]
• Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. [europepmc]
• Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. [europepmc]
• Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability. [europepmc]
• Increased Reactive Oxygen Species-Mediated Ca 2+ /Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and Impaired Contraction in Barth Syndrome. [europepmc]
• CRISPR Modeling and Correction of Cardiovascular Disease. [europepmc]
• Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. [europepmc]
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. [europepmc]
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. [europepmc]
• Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation. [europepmc]

Related

• Role of Sodium and Calcium Dysregulation in Tachyarrhythmias in Sudden Cardiac Death
• Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies
• Translating cardiovascular ion channel and Ca ²⁺ signalling mechanisms into therapeutic insights
• Multiscale studies of delayed afterdepolarizations II: Calcium-overload-induced ventricular arrhythmias
• The effects of intracellular Ca²⁺ on cardiac K⁺ channel expression and activity: novel insights from genetically altered mice